Rho kinase: a target for treating urinary bladder dysfunction?

Trends in Pharmacological Sciences

Volumn 27, Issue 9, 2006, Pages 492-497

  Peters, Stephan L M ^a   Schmidt, Martina ^b   Michel, Martin C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; DARIFENACIN; RHO KINASE; RHO KINASE INHIBITOR;

ALLOXAN DIABETES MELLITUS; BLADDER CONTRACTION; BLADDER DYSFUNCTION; DIABETES MELLITUS; ENZYME ACTIVATION; ESSENTIAL HYPERTENSION; HUMAN; HYPERTROPHY; MICTURITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; URINARY FREQUENCY;

ANIMALS; DIABETES COMPLICATIONS; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; HYPERTENSION; HYPERTROPHY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE CONTRACTION; PROTEIN-SERINE-THREONINE KINASES; URINARY BLADDER; URINARY BLADDER DISEASES;

EID: 33747175707     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2006.07.002     Document Type: Review

References (50)

1. Abrams P., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodyn. 21 (2002) 167-178
2. Milsom I., et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 87 (2001) 760-766
3. Michel M.C., et al. Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder. Eur. Urol. 48 (2005) 110-115
4. Michel M.C., et al. Association of hypertension with symptoms of benign prostatic hyperplasia. J. Urol. 172 (2004) 1390-1393
5. Michel M.C., et al. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J. Urol. 163 (2000) 1725-1729
6. Andersson K.E., and Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol. Rev. 84 (2004) 935-986
7. Holstege G., and Mouton L.J. Central nervous system control of micturition. Int. Rev. Neurobiol. 56 (2003) 123-145
8. Chapple C., et al. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur. Urol. 48 (2005) 5-26
9. Michel M.C., and de la Rosette J.J. Role of muscarinic receptor antagonists in urgency and nocturia. BJU Int. 96 Suppl. 1 (2005) 37-42
10. Rapp D.E., et al. A role for the P2X receptor in urinary tract physiology and in the pathophysiology of urinary dysfunction. Eur. Urol. 48 (2005) 303-308
11. Fukata Y., et al. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 22 (2001) 32-39
12. Kaibuchi K., et al. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu. Rev. Biochem. 68 (1999) 459-486
13. Riento K., and Ridley A.J. Rocks: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell Biol. 4 (2003) 446-456
14. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83 (2003) 1325-1358
15. Chang S., et al. Increased basal phosphorylation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by up-regulation of Rho-kinase β and CPI-17. Am. J. Physiol. Renal Physiol. 290 (2006) F650-F656
16. 2+ sensitization in contraction of human bladder smooth muscle. J. Urol. 172 (2004) 748-752
17. Wibberley A., et al. Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle. Br. J. Pharmacol. 138 (2003) 757-766
18. Rossman K.L., et al. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell Biol. 6 (2005) 167-180
19. Schmidt A., and Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev. 16 (2002) 1587-1609
20. Bernards A., and Settleman J. GAP control: regulating the regulators of small GTPases. Trends Cell Biol. 14 (2004) 377-385
21. DerMardirossian C., and Bokoch G.M. GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol. 15 (2005) 356-363
22. q/11-coupled receptor signaling and RhoA. J. Biol. Chem. 280 (2005) 11134-11139
23. Caulfield M.P., and Birdsall N.J. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 50 (1998) 279-290
24. 3 muscarinic receptor activation of urinary bladder contractile signal transduction. II. Denervated rat bladder. J. Pharmacol. Exp. Ther. 316 (2006) 875-880
25. 3 muscarinic receptor activation of urinary bladder contractile signal transduction. I. Normal rat bladder. J. Pharmacol. Exp. Ther. 316 (2006) 869-874
26. Schneider T., et al. Signal transduction underlying carbachol-induced contraction of human urinary bladder. J. Pharmacol. Exp. Ther. 309 (2004) 1148-1153
27. 2+ sources. J. Pharmacol. Exp. Ther. 308 (2004) 47-53
28. Fleichman M., et al. Signal transduction underlying carbachol-induced contraction of rat urinary bladder. II. Protein kinases. J. Pharmacol. Exp. Ther. 308 (2004) 54-58
29. Jezior J.R., et al. Dependency of detrusor contractions on calcium sensitization and calcium entry through LOE-908-sensitive channels. Br. J. Pharmacol. 134 (2001) 78-87
30. Quinn T., et al. Mechanisms of neurokinin A- and substance P-induced contractions in rat detrusor smooth muscle in vitro. BJU Int. 94 (2004) 651-657
31. Schneider T., et al. A role for muscarinic receptors or rho-kinase in hypertension associated rat bladder dysfunction?. J. Urol. 173 (2005) 2178-2181
32. Speich J.E., et al. ROK-induced cross-link formation stiffens passive muscle: reversible strain-induced stress softening in rabbit detrusor. Am. J. Physiol. Cell Physiol. 289 (2005) C12-C21
33. Ratz P.H., and Miner A.S. Length-dependent regulation of basal myosin phosphorylation and force in detrusor smooth muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (2003) R1063-R1070
34. Hashitani H., et al. Correlation between spontaneous electrical, calcium and mechanical activity in detrusor smooth muscle of the guinea-pig bladder. Br. J. Pharmacol. 141 (2004) 183-193
35. i in smooth muscle strips using front-surface fluorimetry. Methods Mol. Biol. 114 (1999) 269-277
36. Hegde S.S. Muscarinic receptors in the bladder: from basic research to therapeutics. Br. J. Pharmacol. 147 Suppl. 2 (2006) S80-S87
37. Chacko S., et al. Alteration of contractile and regulatory proteins following partial bladder outlet obstruction. Scand. J. Urol. Nephrol. Suppl. 215 (2004) 26-36
38. Levin R.M., et al. Effect of bladder outlet obstruction on the morphology, physiology, and pharmacology of the bladder. Prostate Suppl. 3 (1990) 9-26
39. 2 muscarinic receptor contributes to contraction of the denervated rat urinary bladder. Am. J. Physiol. 275 (1998) R1654-R1660
40. DiSanto M.E., et al. Alteration in expression of myosin isoforms in detrusor smooth muscle following bladder outlet obstruction. Am. J. Physiol. Cell Physiol. 285 (2003) C1397-C1410
41. Zhang E.Y., et al. Smooth muscle hypertrophy following partial bladder outlet obstruction is associated with overexpression of non-muscle caldesmon. Am. J. Pathol. 164 (2004) 601-612
42. Bing W., et al. Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase. Am. J. Physiol. Renal Physiol. 285 (2003) F990-F997
43. Persson K., et al. Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats. Am. J. Physiol. 275 (1998) R1366-R1373
44. Rajasekaran M., et al. Rho-kinase inhibition suppresses bladder hyperactivity in spontaneously hypertensive rats. Neurourol. Urodyn. 24 (2005) 295-300
45. Steers W.D., et al. The spontaneously hypertensive rat: insight into the pathogenesis of irritative symptoms in benign prostatic hyperplasia and young anxious males. Exp. Physiol. 84 (1999) 137-147
46. Uehata M., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389 (1997) 990-994
47. Takahara A., et al. Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model. Eur. J. Pharmacol. 460 (2003) 51-57
48. Ellenberg M. Development of urinary bladder dysfunction in diabetes mellitus. Ann. Intern. Med. 92 (1980) 321-323
49. Eika B., et al. Comparison of urinary bladder function in rats with hereditary diabetes insipidus, streptozotocin-induced diabetes mellitus, and nondiabetic osmotic diuresis. J. Urol. 151 (1994) 496-502
50. Su X., et al. Diabetes decreases rabbit bladder smooth muscle contraction while increasing levels of myosin light chain phosphorylation. Am. J. Physiol. Renal Physiol. 287 (2004) F690-F699